-SEC Filing
Colgate-Palmolive Stock Slips After Q2 Earnings: What’s Going On?
Colgate-Palmolive Company (NYSE: CL) reported second-quarter FY23 sales growth of 7.5% year-on-year to $4.82 billion,
Related Posts
Barrington Research Maintains Outperform on TD Synnex, Lowers Price Target to $106
Barrington Research analyst Vincent Colicchio maintains TD Synnex (NYSE:SNX) with a Outperform and lowers the price target from $128 to $106.
Raymond James Upgrades Dyne Therapeutics to Strong Buy, Raises Price Target to $27
Raymond James analyst Steven Seedhouse upgrades Dyne Therapeutics (NASDAQ:DYN) from Outperform to Strong Buy and raises the price target from $16 to $27.
Horizon Healthcare Services Selects Cognizant To Support Its Government Healthcare Programs For 1.2M Members
Agreement Will Leverage Cognizant's TriZetto Healthcare Products in Support of Horizon's Claims, Encounters, and Enrollment Member ServicesTEANECK, N.J., April 20, 2023 /PRNewswire/ -- Cognizant (NASDAQ:CTSH) has